Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review

AP Mitchell, NU Trivedi, RL Gennarelli… - Annals of internal …, 2021 - acpjournals.org
Background: Financial payments from the drug industry to US physicians are common.
Payments may influence physicians' clinical decision making and drug prescribing. Purpose …

[HTML][HTML] Financial conflicts of interest in clinical practice guidelines: a systematic review

S Tabatabavakili, R Khan, MA Scaffidi… - … : Innovations, Quality & …, 2021 - Elsevier
Objective To systematically evaluate the prevalence of disclosed and undisclosed financial
conflicts of interest (FCOI) among clinical practice guidelines (CPGs). Methods In this …

[HTML][HTML] Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies …

A Murayama, S Kamamoto, H Saito, A Ozaki - Scientific Reports, 2023 - nature.com
There are prevalent financial relationships between dermatologists and pharmaceutical
companies in Japan. However, little was known about the extent of whole picture of the …

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database …

A Murayama, K Nakano, S Kamamoto, M Sato… - Clinical Microbiology …, 2022 - Elsevier
Objective To evaluate the trend in nonresearch payments made by the industries to the
infectious disease physicians in the United States since the launch of the Open Payments …

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019

A Murayama, S Kamamoto, M Kawashima, H Saito… - BMJ open, 2023 - bmjopen.bmj.com
Objectives Limited evidence is available regarding the financial relationships between
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …

Industry‐sponsored meal payments are associated with prescriptions and Medicare expenditures on brand‐name colchicine in the United States

A Murayama - International Journal of Rheumatic Diseases, 2024 - Wiley Online Library
Aim To investigate the association between industry‐sponsored meal payments and the
prescribing patterns of brand‐name colchicines, namely Colcrys and Mitigare, among …

[HTML][HTML] Assessment of financial relationships between otorhinolaryngologists and pharmaceutical companies in Japan between 2016 and 2019

S Kamamoto, A Ozaki, A Murayama - Cureus, 2023 - ncbi.nlm.nih.gov
Introduction: There are prevalent financial relationships between physicians and the
pharmaceutical industry in medical specialties, including otorhinolaryngology. Although …

Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform

T Torgerson, C Wayant, L Cosgrove, EA Akl… - BMJ evidence-based …, 2022 - ebm.bmj.com
Conflicts of interest (COIs) in healthcare are increasingly discussed in the literature, yet
these relationships continue to influence healthcare. Research has consistently shown that …

Comparison of industry payments to psychiatrists and psychiatric advanced practice clinicians in the USA, 2021: a cross-sectional study

J Havlik, L Ososanya, MS Lee, S Wahid, M Heyang… - BMJ open, 2024 - bmjopen.bmj.com
Objectives To compare industry payment patterns among US psychiatrists and psychiatric
advanced practice clinicians (APCs) and determine how scope of practice laws has …

Health care clinicians and product promotion by industry

DS Diekema, Committee on Bioethics - Pediatrics, 2022 - publications.aap.org
Medical pharmaceutical and device manufacturers are essential in making products that
benefit patients, and collaboration between health care clinicians and the industry is …